CD44 and cancer: CSCs from epithelial tissues were first identified in breast cancer in 2003 by Al-Hajj et al.[18], who found that a distinct sub-population of cancer cells expressing CD44+CD24−/low ESA+ develop into tumors in immunodeficient mice.